Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report) was the target of a significant drop in short interest during the month of February. As of February 27th, there was short interest totaling 12,610 shares, a drop of 18.1% from the February 12th total of 15,393 shares. Based on an average daily trading volume, of 2,059 shares, the short-interest ratio is currently 6.1 days. Approximately 1.1% of the company’s shares are sold short. Approximately 1.1% of the company’s shares are sold short. Based on an average daily trading volume, of 2,059 shares, the short-interest ratio is currently 6.1 days.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Mannatech in a research report on Monday, December 22nd. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has an average rating of “Sell”.
Check Out Our Latest Stock Report on Mannatech
Mannatech Price Performance
About Mannatech
Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.
The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.
Read More
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
